
Edvenswa Pharmaceuticals Private Limited
About Edvenswa Pharmaceuticals Private Limited
Data last updated:
Edvenswa Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2021PTC157996. Its GSTIN is 36AAGCE8136L1Z9 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sreenivasa Sreekanth Uppuluri and Basavaraju Ratnakar.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.5 Lakh, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹9.23 Lakh (net margin 19.9%) and EBITDA of ₹12.48 Lakh (EBITDA margin 26.8%).
Company details
Contact details
Edvenswa Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressD.No. 1 – 6 – 149/5/B/1 Edvenswa Towers Bowrampet Dundigal Municipality Medchal – Malkajgir, I District, Hyderabad, Telangana, India – 500043
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Edvenswa Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Edvenswa Pharmaceuticals Private Limited, buy the company report.
Financials of Edvenswa Pharmaceuticals Private Limited
FY 2025 filings availableEdvenswa Pharmaceuticals Private Limited reported revenue of ₹46.5 Lakh (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹12.48 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹9.23 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 26.8% | |||
| Net Profit Margin | 19.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Edvenswa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Edvenswa Pharmaceuticals Private Limited
Edvenswa Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreenivasa Sreekanth Uppuluri | Director | 16 Dec 2021 | 4 Years 11 Months | Current |
| Basavaraju Ratnakar Also directs: Edvenswa Tech Private Limited, Edvenswa Motors Private Limited, Strategemist Global Private Limited and 1 more | Director | 16 Dec 2021 | 4 Years 11 Months | Current |
| Uppuluri Anupama | Director | 16 Dec 2021 | 4 Years 11 Months | Current |
Peer comparison
Edvenswa Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Agro Tech Aromatics Private Limited | ₹46.78 Lakh (FY 2025) | 508.0% | Jammu, Jammu and Kashmir, India | |||
| Mother Land Pharmaceuticals Private Limited | ₹46.68 Lakh (FY 2024) | 10.0% | Kumbakonam, Tamil Nadu, India | |||
| Heglems Pharmaceuticals Private Limited | ₹46.59 Lakh (FY 2024) | 212.0% | Delhi, India | |||
| Edvenswa Pharmaceuticals Private Limitedthis company | ₹46.5 Lakh (FY 2025) | ₹9.23 Lakh | 19.9% | -9.0% | Hyderabad, Telangana, India | |
| Ramdular Pharmaceutical Private Limited | ₹46.44 Lakh (FY 2024) | 7.0% | Ratnagiri, Maharashtra, India | |||
| Esan Pharmaceuticals Private Limited | ₹46.41 Lakh (FY 2025) | -11.0% | New Delhi, Delhi, India |
To see the full peer comparison of Edvenswa Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Edvenswa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Edvenswa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Edvenswa Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCE8136L1Z9 | Telangana | Active | 28 Apr 2022 |
To see the full GST registrations and return filing status of Edvenswa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Edvenswa Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Basavaraju Ratnakar was appointed as Director on 16 Dec 2021.
Frequently asked questions
Edvenswa Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 December 2021 (5+ years old) and is registered under CIN U24299TG2021PTC157996.
Edvenswa Pharmaceuticals has 3 current directors:
- Sreenivasa Sreekanth Uppuluri - Director
- Basavaraju Ratnakar - Director
- Uppuluri Anupama - Director
The latest financial statements of Edvenswa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Edvenswa Pharmaceuticals is 36AAGCE8136L1Z9, registered in Telangana.
The CIN (Corporate Identification Number) of Edvenswa Pharmaceuticals is U24299TG2021PTC157996. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Edvenswa Pharmaceuticals was incorporated on 16 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Edvenswa Pharmaceuticals by revenue are Agro Tech Aromatics Private Limited, Mother Land Pharmaceuticals Private Limited, Heglems Pharmaceuticals Private Limited, Ramdular Pharmaceutical Private Limited, Esan Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Basavaraju Ratnakar was appointed as Director on 16 Dec 2021. Sreenivasa Sreekanth Uppuluri was appointed as Director on 16 Dec 2021. Uppuluri Anupama was appointed as Director on 16 Dec 2021.
The registered office of Edvenswa Pharmaceuticals is at D.No. 1 – 6 – 1495B1 Edvenswa Towers Bowrampet Dundigal Municipality Medchal – Malkajgir, I District, Hyderabad, Telangana, India – 500043.
Edvenswa Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Edvenswa Pharmaceuticals can be reached at its registered office: D.No. 1 – 6 – 1495B1 Edvenswa Towers Bowrampet Dundigal Municipality Medchal – Malkajgir, I District, Hyderabad, Telangana, India – 500043.

